{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:20:30Z","timestamp":1793319630514,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1183597"],"award-info":[{"award-number":["APP1183597"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1183597"],"award-info":[{"award-number":["APP1183597"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myopia has become a leading cause of visual impairment globally, with a rapidly increasing prevalence among children, particularly in urbanised areas of East and Southeast Asia. High and pathologic myopia can lead to irreversible complications, including retinal detachment, glaucoma, and myopic maculopathy. This narrative review synthesises current and emerging strategies for myopia control as of 2025, integrating evidence from optical, pharmacological, behavioural, and surgical domains. Multifocal contact lenses, orthokeratology, and defocus-incorporated spectacles are effective in modulating axial elongation. Low-dose atropine remains a cornerstone pharmacologic therapy with consistent efficacy. Behavioural interventions, such as increased outdoor time, provide preventive benefits and are endorsed in school-based programs. Repeated low-level red-light (RLRL) therapy represents a novel, non-invasive option with growing support. Surgical approaches, while corrective rather than preventive, are relevant in advanced cases. The review also compares intervention efficacy, discusses the rationale for combination therapies, and highlights the need for individualised, age-appropriate strategies. Key challenges include treatment variability, limited long-term data, and barriers to adherence and access. Future directions involve personalised risk prediction, global implementation frameworks, and public health engagement. A multimodal, patient-centred approach is essential to reduce the lifelong burden of myopia.<\/jats:p>","DOI":"10.1038\/s41433-025-03949-1","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T13:12:25Z","timestamp":1754053945000},"page":"2635-2644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Current and emerging strategies for myopia control: a narrative review of optical, pharmacological, behavioural, and adjunctive therapies"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-2504","authenticated-orcid":false,"given":"Furqan A.","family":"Maulvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditixa T.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathi","family":"Kalaiselvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh O.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D. P.","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"3949_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3390\/jcm12041317","volume":"12","author":"JB Jonas","year":"2023","unstructured":"Jonas JB, Bikbov MM, Wang Y-X, Jonas RA, Panda-Jonas S. Anatomic peculiarities associated with axial elongation of the myopic eye. J Clin Med. 2023;12:1317.","journal-title":"J Clin Med"},{"key":"3949_CR2","first-page":"120","volume":"2","author":"AS George","year":"2023","unstructured":"George AS, George AH, Shahul A. The myopia epidemic: a growing public health crisis impacting children worldwide. Partn Univers Int Res J. 2023;2:120\u201338.","journal-title":"Partn Univers Int Res J"},{"key":"3949_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.oret.2022.06.009","volume":"6","author":"MV Cicinelli","year":"2022","unstructured":"Cicinelli MV, La Franca L, De Felice E, Rabiolo A, Marchese A, Battaglia Parodi M, et al. Long-term incidence and risk factors of macular fibrosis, macular atrophy, and macular hole in eyes with myopic neovascularization. Ophthalmol Retin. 2022;6:1231\u201340.","journal-title":"Ophthalmol Retin"},{"key":"3949_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/bjo-2024-325427","volume":"109","author":"J Liang","year":"2025","unstructured":"Liang J, Pu Y, Chen J, Liu M, Ouyang B, Ouyang B, et al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br J Ophthalmol. 2025;109:362\u201371.","journal-title":"Br J Ophthalmol"},{"key":"3949_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/opo.12806","volume":"41","author":"JJ Priscilla","year":"2021","unstructured":"Priscilla JJ, Verkicharla PK. Time trends on the prevalence of myopia in India\u2013A prediction model for 2050. Ophthal Physio Opt. 2021;41:466\u201374.","journal-title":"Ophthal Physio Opt"},{"key":"3949_CR6","first-page":"01","volume":"14","author":"MF Ansari","year":"2023","unstructured":"Ansari MF, Ahmad A. Digital screen time and myopia: a review. EC Ophthalmol. 2023;14:01\u201309.","journal-title":"EC Ophthalmol"},{"key":"3949_CR7","first-page":"1004977","volume":"2022","author":"A Russo","year":"2022","unstructured":"Russo A, Boldini A, Romano D, Mazza G, Bignotti S, Morescalchi F, et al. Myopia: mechanisms and strategies to slow down its progression. J Ophthalmol 2022. 2022;2022:1004977.","journal-title":"J Ophthalmol 2022"},{"key":"3949_CR8","unstructured":"E. National Academies of Sciences, Medicine, Current and Emerging Treatment Options for Myopia, Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease, National Academies Press (US) 2024."},{"key":"3949_CR9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijms.85746","volume":"20","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Cao X, Zhang Y, Zhou Y, Zhang J, Zhang X, et al. Repeated low-level red-light therapy for controlling onset and progression of myopia-a review. Int J Med Sci. 2023;20:1363\u201376.","journal-title":"Int J Med Sci"},{"key":"3949_CR10","unstructured":"Lee L, Barclay E, Tahhan N, Resnikoff S, et al. A response to the latest global projection of myopia prevalence in children and adolescents in 2050. 2024;23:1655-65."},{"key":"3949_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jamaophthalmol.2021.5347","volume":"140","author":"DS Ng","year":"2022","unstructured":"Ng DS, Lai TY. Insights into the global epidemic of high myopia and its implications. JAMA Ophthalmol. 2022;140:123\u20134.","journal-title":"JAMA Ophthalmol"},{"key":"3949_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036\u201342.","journal-title":"Ophthalmology"},{"key":"3949_CR13","doi-asserted-by":"publisher","first-page":"924566","DOI":"10.3389\/fpubh.2022.924566","volume":"10","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li Z, Ren J, Wang W, Dai J, Li C, et al. Prevalence of myopia: A large-scale population-based study among children and adolescents in weifang, china. Front Public Health. 2022;10:924566.","journal-title":"Front Public Health"},{"key":"3949_CR14","first-page":"101484","volume":"55","author":"W Pan","year":"2025","unstructured":"Pan W, Saw S-M, Wong TY, Morgan I, Yang Z, Lan W. Prevalence and temporal trends in myopia and high myopia children in China: a systematic review and meta-analysis with projections from 2020 to 2050. Lancet Reg Health\u2013West Pac. 2025;55:101484.","journal-title":"Lancet Reg Health\u2013West Pac"},{"key":"3949_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100350","volume":"3","author":"E Ueda","year":"2023","unstructured":"Ueda E, Yasuda M, Fujiwara K, Hashimoto S, Honda T, Nakamura S, et al. Association between choroidal thickness and myopic maculopathy in a Japanese population: the Hisayama Study. Ophthalmol Sci. 2023;3:100350.","journal-title":"Ophthalmol Sci"},{"key":"3949_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42108-y","volume":"13","author":"MA Bullimore","year":"2023","unstructured":"Bullimore MA, Brennan NA. The underestimated role of myopia in uncorrectable visual impairment in the United States. Sci Rep. 2023;13:15283.","journal-title":"Sci Rep"},{"key":"3949_CR17","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3390\/jcm12083045","volume":"12","author":"B Banashefski","year":"2023","unstructured":"Banashefski B, Rhee MK, Lema GM. High myopia prevalence across racial groups in the United States: a systematic scoping review. J Clin Med. 2023;12:3045.","journal-title":"J Clin Med"},{"key":"3949_CR18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/ceo.13980","volume":"49","author":"DA Mackey","year":"2021","unstructured":"Mackey DA, Lingham G, Lee SS, Hunter M, Wood D, Hewitt AW, et al. Change in the prevalence of myopia in Australian middle-aged adults across 20 years. Clin Exp Ophthalmol. 2021;49:1039\u201347.","journal-title":"Clin Exp Ophthalmol"},{"key":"3949_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/bjophthalmol-2017-310292","volume":"102","author":"JWL Tideman","year":"2018","unstructured":"Tideman JWL, Polling JR, Hofman A, Jaddoe VW, Mackenbach JP, Klaver CC. Environmental factors explain socioeconomic prevalence differences in myopia in 6-year-old children. Br J Ophthalmol. 2018;102:243\u20137.","journal-title":"Br J Ophthalmol"},{"key":"3949_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/qjmed\/hcz076","volume":"116","author":"CM Bourke","year":"2023","unstructured":"Bourke CM, Loughman J, Flitcroft DI, Loskutova E, O'Brien C. We can\u2019t afford to turn a blind eye to myopia. QJM: Int J Med. 2023;116:635\u20139.","journal-title":"QJM: Int J Med"},{"key":"3949_CR21","doi-asserted-by":"publisher","first-page":"718724","DOI":"10.3389\/fmed.2021.718724","volume":"8","author":"LL Foo","year":"2021","unstructured":"Foo LL, Lanca C, Wong CW, Ting D, Lamoureux E, Saw SM, et al. Cost of myopia correction: a systematic review. Front Med. 2021;8:718724.","journal-title":"Front Med"},{"key":"3949_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bjophthalmol-2021-319306","volume":"107","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Chen Y, Tan Z, Xiong R, McGuinness MB, M\u00fcller A. Interventions recommended for myopia prevention and control among children and adolescents in China: a systematic review. Br J Ophthalmol. 2023;107:160\u20136.","journal-title":"Br J Ophthalmol"},{"key":"3949_CR23","first-page":"156","volume":"4","author":"Y Du","year":"2024","unstructured":"Du Y, Meng J, He W, Qi J, Lu Y, Zhu X. Complications of high myopia: an update from clinical manifestations to underlying mechanisms. Adv Ophthalmol Pr Res. 2024;4:156\u201363.","journal-title":"Adv Ophthalmol Pr Res"},{"key":"3949_CR24","doi-asserted-by":"publisher","first-page":"112472","DOI":"10.1016\/j.biopha.2021.112472","volume":"145","author":"J Yang","year":"2022","unstructured":"Yang J, Ouyang X, Fu H, Hou X, Liu Y, Xie Y, et al. Advances in biomedical study of the myopia-related signaling pathways and mechanisms. Biomed Pharmacother. 2022;145:112472.","journal-title":"Biomed Pharmacother"},{"key":"3949_CR25","first-page":"173","volume":"4","author":"L Zheng","year":"2024","unstructured":"Zheng L, Liao Z, Zou J. Animal modeling for myopia. Adv Ophthalmol Pr Res. 2024;4:173\u201381.","journal-title":"Adv Ophthalmol Pr Res"},{"key":"3949_CR26","first-page":"3825","volume":"17","author":"A Ehongo","year":"2023","unstructured":"Ehongo A. Understanding posterior staphyloma in pathologic myopia: Current overview, new input, and perspectives. ClinOphthalmol. 2023;17:3825\u201353.","journal-title":"ClinOphthalmol"},{"key":"3949_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41572-020-00231-4","volume":"6","author":"PN Baird","year":"2020","unstructured":"Baird PN, Saw SM, Lanca C, Guggenheim JA, Smith Iii EL, Zhou X, et al. Myopia. Nat Rev Dis Prim. 2020;6:99.","journal-title":"Nat Rev Dis Prim"},{"key":"3949_CR28","doi-asserted-by":"crossref","unstructured":"JB Jonas, S Panda-Jonas, L Dong, RA Jonas. Clinical and anatomical features of myopia, Asia-Pac J Ophthalmol. 2024;13:100114.","DOI":"10.1016\/j.apjo.2024.100114"},{"key":"3949_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/00006324-198707000-00012","volume":"64","author":"T Grosvenor","year":"1987","unstructured":"Grosvenor T. A review and a suggested classification system for myopia on the basis of age-related prevalence and age of onset. Am J Optom Physiol Opt. 1987;64:545\u201354.","journal-title":"Am J Optom Physiol Opt"},{"key":"3949_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/00006324-199103000-00008","volume":"68","author":"T Grosvenor","year":"1991","unstructured":"Grosvenor T, Scott R. Comparison of refractive components in youth-onset and early adult-onset myopia. Optom Vis Sci. 1991;68:204\u20139.","journal-title":"Optom Vis Sci"},{"key":"3949_CR31","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/diagnostics12061418","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Zheng F, Foo LL, Wong QY, Ting D, Hoang QV, et al. Advances in OCT imaging in myopia and pathologic myopia. Diagnostics. 2022;12:1418.","journal-title":"Diagnostics"},{"key":"3949_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/ICL.0000000000000917","volume":"48","author":"N Raval","year":"2022","unstructured":"Raval N, Kang JJ, Kim YH. A review of pathologic myopia. Eye Contact Lens. 2022;48:403\u20139.","journal-title":"Eye Contact Lens"},{"key":"3949_CR33","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1111\/aos.15746","volume":"102","author":"S Sarkar","year":"2024","unstructured":"Sarkar S, Khuu S, Kang P. A systematic review and meta-analysis of the efficacy of different optical interventions on the control of myopia in children. Acta ophthalmol. 2024;102:e229\u2013e244.","journal-title":"Acta ophthalmol"},{"key":"3949_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2020.10834","volume":"324","author":"JJ Walline","year":"2020","unstructured":"Walline JJ, Walker MK, Mutti DO, Jones-Jordan LA, Sinnott LT, Giannoni AG, et al. Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial. Jama. 2020;324:571\u201380.","journal-title":"Jama"},{"key":"3949_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clae.2019.11.002","volume":"43","author":"JS Wolffsohn","year":"2020","unstructured":"Wolffsohn JS, Calossi A, Cho P, Gifford K, Jones L, Jones D, et al. Global trends in myopia management attitudes and strategies in clinical practice\u20132019. Update, Contact Lens Anterior Eye. 2020;43:9\u201317.","journal-title":"Update, Contact Lens Anterior Eye"},{"key":"3949_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/ICL.0000000000001043","volume":"49","author":"T Peng","year":"2023","unstructured":"Peng T, Jiang J. Efficiency and related factors of multifocal soft contact lenses in controlling myopia. Eye Contact Lens. 2023;49:535\u201341.","journal-title":"Eye Contact Lens"},{"key":"3949_CR37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s40123-022-00536-5","volume":"11","author":"EP Shen","year":"2022","unstructured":"Shen EP, Chu H-S, Cheng H-C, Tsai TH. Center-for-near extended-depth-of-focus soft contact lens for myopia control in children: 1-year results of a randomized controlled trial. Ophthalmol Ther. 2022;11:1577\u201388.","journal-title":"Ophthalmol Ther"},{"key":"3949_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/bjo-2023-323887","volume":"109","author":"XJ Zhang","year":"2025","unstructured":"Zhang XJ, Zaabaar E, French AN, Tang FY, Kam KW, Tham CC, et al. Advances in myopia control strategies for children. Br J Ophthalmol. 2025;109:165\u201376.","journal-title":"Br J Ophthalmol"},{"key":"3949_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY, Lee RPK, Chun R, Hasegawa K, et al. To, Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104:363\u20138.","journal-title":"Br J Ophthalmol"},{"key":"3949_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2024.102167","volume":"47","author":"B Yang","year":"2024","unstructured":"Yang B, Liu L, Cho P. Effectiveness of orthokeratology and myopia control spectacles in a real-world setting in China. Contact Lens Anterior Eye. 2024;47:102167.","journal-title":"Contact Lens Anterior Eye"},{"key":"3949_CR41","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho P, Cheung S-W. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Investig Ophthalmol Vis Sci. 2012;53:7077\u201385.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3949_CR42","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.jfma.2022.05.005","volume":"121","author":"H-R Tsai","year":"2022","unstructured":"Tsai H-R, Wang J-H, Huang H-K, Chen T-L, Chen PW, Chiu CJ. Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: a systematic review and network meta-analysis. J Formos Med Assoc. 2022;121:2490\u20132500.","journal-title":"J Formos Med Assoc"},{"key":"3949_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/jamaophthalmol.2023.5467","volume":"142","author":"Y Li","year":"2024","unstructured":"Li Y, Yip M, Ning Y, Chung J, Toh A, Leow C, et al. Topical atropine for childhood myopia control: the atropine treatment long-term assessment study. JAMA Ophthalmol. 2024;142:15\u201323.","journal-title":"JAMA Ophthalmol"},{"key":"3949_CR44","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3390\/pharmaceutics14050900","volume":"14","author":"A Chierigo","year":"2022","unstructured":"Chierigo A, Ferro Desideri L, Traverso CE, Vagge A. The role of atropine in preventing myopia progression: an update. Pharmaceutics. 2022;14:900.","journal-title":"Pharmaceutics"},{"key":"3949_CR45","first-page":"157","volume":"7","author":"R Kaiti","year":"2022","unstructured":"Kaiti R, Shyangbo R, Sharma I.P. Role of atropine in the control of myopia progression-a review. Beyoglu Eye J. 2022;7:157.","journal-title":"Beyoglu Eye J"},{"key":"3949_CR46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","volume":"157","author":"A Chia","year":"2014","unstructured":"Chia A, Chua W-H, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157:451\u201347.e1.","journal-title":"Am J Ophthalmol"},{"key":"3949_CR47","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua W-H, Cheung Y-B, Wong W-L, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012;119:347\u201354.","journal-title":"Ophthalmology"},{"key":"3949_CR48","first-page":"360","volume":"8","author":"FF Li","year":"2019","unstructured":"Li FF, Yam JC. Low-concentration atropine eye drops for myopia progression, Asia-Pacific. J Ophthalmol. 2019;8:360.","journal-title":"J Ophthalmol"},{"key":"3949_CR49","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang X, Tang SM, Yip B, Kam KW, et al. Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report. Ophthalmology. 2020;127:910\u20139.","journal-title":"Ophthalmology"},{"key":"3949_CR50","first-page":"1535","volume":"104","author":"A Fu","year":"2020","unstructured":"Fu A, Stapleton F, Wei L, Wang W, Zhao B, Watt K, et al. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression. Br J Ophthalmol. 2020;104:1535\u201341.","journal-title":"Br J Ophthalmol"},{"key":"3949_CR51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/opo.12052","volume":"33","author":"NA McBrien","year":"2013","unstructured":"McBrien NA, Stell WK, Carr B. How does atropine exert its anti-myopia effects?. OphthalH Physiol Opt. 2013;33:373\u20138.","journal-title":"OphthalH Physiol Opt"},{"key":"3949_CR52","unstructured":"News Medical Editorial Team. Low-dose atropine eyedrops not effective in slowing myopia progression in children. News-Medical.net. Manchester (UK): AZoNetwork; 2023 [cited 2025 Jul 30]. Available from: https:\/\/www.news-medical.net\/news\/20230801\/Low-doseatropine-eyedrops-not-effective-in-slowing-myopia-progression-in-children.aspx"},{"key":"3949_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ophtha.2004.06.038","volume":"112","author":"DT Tan","year":"2005","unstructured":"Tan DT, Lam DS, Chua WH, Shu-Ping DF, Crockett RS, Asian Pirenzepine Study G. Group, One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmology. 2005;112:84\u201391.","journal-title":"Ophthalmology"},{"key":"3949_CR54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jaapos.2007.10.014","volume":"12","author":"RM Siatkowski","year":"2008","unstructured":"Siatkowski RM, Cotter SA, Crockett RS, Miller JM, Novack GD, Zadnik K, et al. Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. J Am Assoc Pediatr Ophthalmol Strabismus. 2008;12:332\u20139.","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"3949_CR55","doi-asserted-by":"publisher","first-page":"100010","DOI":"10.1016\/j.ajoint.2024.100010","volume":"1","author":"M Ba","year":"2024","unstructured":"Ba M, Li Z. The impact of lifestyle factors on myopia development: insights and recommendations. AJO Int. 2024;1:100010.","journal-title":"AJO Int"},{"key":"3949_CR56","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ophtha.2022.06.024","volume":"129","author":"X He","year":"2022","unstructured":"He X, Sankaridurg P, Wang J, Chen J, Naduvilath T, He M, et al. Time outdoors in reducing myopia: a school-based cluster randomized trial with objective monitoring of outdoor time and light intensity. Ophthalmology. 2022;129:1245\u201354.","journal-title":"Ophthalmology"},{"key":"3949_CR57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.62.1.28","volume":"62","author":"EG Landis","year":"2021","unstructured":"Landis EG, Park HN, Chrenek M, He L, Sidhu C, Chakraborty R, et al. Ambient light regulates retinal dopamine signaling and myopia susceptibility. Investig Ophthalmol Vis Sci. 2021;62:28\u201328.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3949_CR58","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2015.10803","volume":"314","author":"M He","year":"2015","unstructured":"He M, Xiang F, Zeng Y, Mai J, Chen Q, Zhang J, et al. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. Jama. 2015;314:1142\u20138.","journal-title":"Jama"},{"key":"3949_CR59","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.ophtha.2017.12.011","volume":"125","author":"P-C Wu","year":"2018","unstructured":"Wu P-C, Chen C-T, Lin K-K, Sun C-C, Kuo CN, Huang HM, et al. Myopia prevention and outdoor light intensity in a school-based cluster randomized trial. Ophthalmology. 2018;125:1239\u201350.","journal-title":"Ophthalmology"},{"key":"3949_CR60","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.ophtha.2020.01.054","volume":"127","author":"P-C Wu","year":"2020","unstructured":"Wu P-C, Chen C-T, Chang L-C, Niu Y-Z, Chen ML, Liao LL, et al. Increased time outdoors is followed by reversal of the long-term trend to reduced visual acuity in Taiwan primary school students. Ophthalmology. 2020;127:1462\u20139.","journal-title":"Ophthalmology"},{"key":"3949_CR61","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/ijerph20010875","volume":"20","author":"F Dutheil","year":"2023","unstructured":"Dutheil F, Oueslati T, Delamarre L, Castanon J, Maurin C, Chiambaretta F, et al. Myopia and near work: a systematic review and meta-analysis. Int J Environ Res public health. 2023;20:875.","journal-title":"Int J Environ Res public health"},{"key":"3949_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/OPX.0000000000001965","volume":"100","author":"AD Pucker","year":"2023","unstructured":"Pucker AD, Gawne TJ. Fighting myopia with intermittent nearwork breaks: 20 seconds every 20\u2009min might not be enough time. Optom Vis Sci. 2023;100:31\u201332.","journal-title":"Optom Vis Sci"},{"key":"3949_CR63","doi-asserted-by":"publisher","first-page":"e239612","DOI":"10.1001\/jamanetworkopen.2023.9612","volume":"6","author":"X He","year":"2023","unstructured":"He X, Wang J, Zhu Z, Xiang K, Zhang X, Zhang B, et al. Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial. JAMA Netw open. 2023;6:e239612\u2013e239612.","journal-title":"JAMA Netw open"},{"key":"3949_CR64","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/opo.13404","volume":"45","author":"A Xiang","year":"2025","unstructured":"Xiang A, He H, Li A, Meng X, Luo Y, Luo Y, et al. Changes in choroidal thickness and blood flow in response to form deprivation-induced myopia and repeated low-level red-light therapy in Guinea pigs. Ophthalmic Physiol Opt. 2025;45:111\u20139.","journal-title":"Ophthalmic Physiol Opt"},{"key":"3949_CR65","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","volume":"129","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, Zhang J, et al. Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. Ophthalmology. 2022;129:509\u201319.","journal-title":"Ophthalmology"},{"key":"3949_CR66","unstructured":"Tanuja, B. Enhancement of dissolution rate of Rosuvastatin calcium by complexation with \u03b2-cyclodextrins. Scholars Academic Journal of Pharmacy 2024;6:101\u2013107"},{"key":"3949_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2023.102094","volume":"47","author":"J Zhang","year":"2024","unstructured":"Zhang J, Li Z, Cheng Z, Wang T, Shi W. Comparison of the clinical efficacy of orthokeratology and 0.01% atropine for retardation of myopia progression in myopic children. Contact Lens Anterior Eye. 2024;47:102094.","journal-title":"Contact Lens Anterior Eye"},{"key":"3949_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2022.101723","volume":"46","author":"Q Tan","year":"2023","unstructured":"Tan Q, Ng AL, Cheng GP, Woo VC, Cho P. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Contact Lens Anterior Eye. 2023;46:101723.","journal-title":"Contact Lens Anterior Eye"},{"key":"3949_CR69","doi-asserted-by":"publisher","first-page":"e0281816","DOI":"10.1371\/journal.pone.0281816","volume":"18","author":"P Nucci","year":"2023","unstructured":"Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans B. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine. PLoS One. 2023;18:e0281816.","journal-title":"PLoS One"},{"key":"3949_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25599-z","volume":"12","author":"Z Huang","year":"2022","unstructured":"Huang Z, Chen X-F, He T, Tang Y, Du CX. Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia. Sci Rep. 2022;12:22311.","journal-title":"Sci Rep"},{"key":"3949_CR71","first-page":"580","volume":"9","author":"X-J Li","year":"2016","unstructured":"Li X-J, Yang X-P, Li Q-M, Wang Y-Y, Wang Y, Lyu XB, et al. Posterior scleral reinforcement for the treatment of pathological myopia. Int J Ophthalmol. 2016;9:580\u20134.","journal-title":"Int J Ophthalmol"},{"key":"3949_CR72","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/112067210201200507","volume":"12","author":"N Gabri\u0107","year":"2002","unstructured":"Gabri\u0107 N, Dekaris I, Karaman \u017d. Refractive lens exchange for correction of high myopia. Eur J Ophthalmol. 2002;12:384\u20137.","journal-title":"Eur J Ophthalmol"},{"key":"3949_CR73","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/JCMA.0000000000000674","volume":"85","author":"J-Y Chang","year":"2022","unstructured":"Chang J-Y, Lin P-Y, Hsu C-C, Liu CJ-L. Comparison of clinical outcomes of LASIK, Trans-PRK, and SMILE for correction of myopia. J Chin Med Assoc. 2022;85:145\u201351.","journal-title":"J Chin Med Assoc"},{"key":"3949_CR74","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1167\/iovs.17-23707","volume":"59","author":"A Xue","year":"2018","unstructured":"Xue A, Zheng L, Tan G, Wu S, Wu Y, Cheng L, et al. Genipin-crosslinked donor sclera for posterior scleral contraction\/reinforcement to fight progressive myopia. Investig Ophthalmol Vis Sci. 2018;59:3564\u201373.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3949_CR75","doi-asserted-by":"publisher","first-page":"1543864","DOI":"10.3389\/fmed.2025.1543864","volume":"12","author":"L-l Nie","year":"2025","unstructured":"Nie L-l, Ma X, Pei Y. Subjective and objective changes in visual quality after implantable collamer lens implantation for myopia. Front Med. 2025;12:1543864.","journal-title":"Front Med"},{"key":"3949_CR76","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ophtha.2024.03.013","volume":"131","author":"XJ Zhang","year":"2024","unstructured":"Zhang XJ, Zhang Y, Yip B, Kam KW, Tang F, Ling X, et al. Five-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: Phase 4 report. Ophthalmology. 2024;131:1011\u201320.","journal-title":"Ophthalmology"},{"key":"3949_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2021.101517","volume":"46","author":"Z Chen","year":"2023","unstructured":"Chen Z, Zhang Z, Xue F, Zhou J, Zeng L, Qu X, et al. The relationship between myopia progression and axial elongation in children wearing orthokeratology contact lenses. Contact Lens Anterior Eye. 2023;46:101517.","journal-title":"Contact Lens Anterior Eye"},{"key":"3949_CR78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.66.5.5","volume":"66","author":"MK Walker","year":"2025","unstructured":"Walker MK, Berntsen DA, Robich ML, Fenton RL, Ticak A, Assaad JR, et al. Three-Year Change in Subfoveal Choroidal Thickness and Area With Multifocal Contact Lens Wear in the Bifocal Lenses in Nearsighted Kids (BLINK) Study. Investig Ophthalmol Vis Sci. 2025;66:5\u20135.","journal-title":"Investig Ophthalmol Vis Sci"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03949-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03949-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03949-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T11:02:56Z","timestamp":1758193376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03949-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":78,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3949"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03949-1","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}